# Safety and Efficacy Study of Cefdinir Oral Suspension, in Pediatric Subjects to Treat Acute Otitis Media

> **NCT00645203** · PHASE2,PHASE3 · COMPLETED · sponsor: **Abbott** · enrollment: 447 (actual)

## Conditions studied

- Acute Otitis Media

## Interventions

- **DRUG:** cefdinir

## Key facts

- **NCT ID:** NCT00645203
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-07
- **Primary completion:** 2003-04
- **Final completion:** —
- **Target enrollment:** 447 (ACTUAL)
- **Last updated:** 2008-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00645203

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00645203, "Safety and Efficacy Study of Cefdinir Oral Suspension, in Pediatric Subjects to Treat Acute Otitis Media". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00645203. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*